Hi, everybody. Does anyone know what dosing schedule the Open Medicine Institute clinic is using for patients they give Rituximab? I know there was a thread recently on Rituximab at OMI, but it doesn't seem like anyone was able to confirm the schedule OMI is using. Are they using: - The Norwegians' original schedule (two 1,000 mg infusions, two weeks apart, without any maintenance infusions); - The open-label phase 2 schedule (six 1,000 mg infusions over 15 months); or - The new phase 3 schedule (two 1,000 mg infusions, then four 500 mg fixed infusions, all over 12 months)? (I say 1,000 mg in the interest of brevity; I know it might be slightly lower depending on body surface area.) And does anyone know how OMI figures out whether one of their patients is a "good candidate" for Rituximab? Or do they pretty much give it to any ME patient who is willing to pay out-of-pocket and isn't an infection risk? I've emailed OMI directly about this, but I have no idea whether to expect a response. Finally, does anyone know of any places in the US other than OMI that are using Rituximab to treat ME? @deleder2k, I know you're in Norway, but do you have any info here? Thanks in advance, everyone.